These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 18855877

  • 1. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
    Filion C, Motoi T, Olshen AB, Laé M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y.
    J Pathol; 2009 Jan; 217(1):83-93. PubMed ID: 18855877
    [Abstract] [Full Text] [Related]

  • 2. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
    Noguchi H, Mitsuhashi T, Seki K, Tochigi N, Tsuji M, Shimoda T, Hasegawa T.
    Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
    [Abstract] [Full Text] [Related]

  • 3. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
    Brenca M, Stacchiotti S, Fassetta K, Sbaraglia M, Janjusevic M, Racanelli D, Polano M, Rossi S, Brich S, Dagrada GP, Collini P, Colombo C, Gronchi A, Astolfi A, Indio V, Pantaleo MA, Picci P, Casali PG, Dei Tos AP, Pilotti S, Maestro R.
    J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
    Laflamme C, Filion C, Bridge JA, Ladanyi M, Goldring MB, Labelle Y.
    Cancer Res; 2003 Jan 15; 63(2):449-54. PubMed ID: 12543801
    [Abstract] [Full Text] [Related]

  • 9. Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
    Stacchiotti S, Pantaleo MA, Astolfi A, Dagrada GP, Negri T, Dei Tos AP, Indio V, Morosi C, Gronchi A, Colombo C, Conca E, Toffolatti L, Tazzari M, Crippa F, Maestro R, Pilotti S, Casali PG.
    Eur J Cancer; 2014 Jun 15; 50(9):1657-64. PubMed ID: 24703573
    [Abstract] [Full Text] [Related]

  • 10. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
    Broehm CJ, Wu J, Gullapalli RR, Bocklage T.
    Cancer Genet; 2014 Jun 15; 207(6):276-80. PubMed ID: 25130955
    [Abstract] [Full Text] [Related]

  • 11. Next generation sequencing of extraskeletal myxoid chondrosarcoma.
    Davis EJ, Wu YM, Robinson D, Schuetze SM, Baker LH, Athanikar J, Cao X, Kunju LP, Chinnaiyan AM, Chugh R.
    Oncotarget; 2017 Mar 28; 8(13):21770-21777. PubMed ID: 28423517
    [Abstract] [Full Text] [Related]

  • 12. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.
    Huang SC, Lee JC, Hsu YC, Tsai JW, Kao YC, Hsieh TH, Chang YM, Chang KC, Wu PS, Chen PC, Chen CH, Chang CD, Lee PH, Tai HC, Liu TT, Wen MC, Li WS, Yu SC, Wang JC, Huang HY.
    Mod Pathol; 2023 Jul 28; 36(7):100161. PubMed ID: 36948401
    [Abstract] [Full Text] [Related]

  • 13. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
    Lenz J, Klubíčková N, Ptáková N, Hájková V, Grossmann P, Šteiner P, Kinkor Z, Švajdler M, Michal M, Konečná P, Macháčová D, Hurník P, Tichý M, Tichý F, Kyllar M, Fiala L, Kavka M, Michal M.
    Hum Pathol; 2023 Apr 28; 134():19-29. PubMed ID: 36563884
    [Abstract] [Full Text] [Related]

  • 14. A novel sarcoma with dual differentiation: clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma.
    Vergara-Lluri ME, Stohr BA, Puligandla B, Brenholz P, Horvai AE.
    Am J Surg Pathol; 2012 Jul 28; 36(7):1093-8. PubMed ID: 22743288
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
    Ngo C, Verret B, Vibert J, Cotteret S, Levy A, Pechoux CL, Haddag-Miliani L, Honore C, Faron M, Quinquis F, Cesne AL, Scoazec JY, Pierron G.
    Genes Chromosomes Cancer; 2023 Jan 28; 62(1):52-56. PubMed ID: 35932215
    [Abstract] [Full Text] [Related]

  • 17. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone.
    Demicco EG, Wang WL, Madewell JE, Huang D, Bui MM, Bridge JA, Meis JM.
    Am J Surg Pathol; 2013 May 28; 37(5):752-62. PubMed ID: 23588370
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The TFG-TEC oncoprotein induces transcriptional activation of the human β-enolase gene via chromatin modification of the promoter region.
    Kim AY, Lim B, Choi J, Kim J.
    Mol Carcinog; 2016 Oct 28; 55(10):1411-23. PubMed ID: 26310886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.